Johnson Johnson Stock Fundamentals
| JNJ Stock | USD 155.40 0.88 0.57% |
Johnson Johnson fundamentals help investors to digest information that contributes to Johnson Johnson's financial success or failures. It also enables traders to predict the movement of Johnson Stock. The fundamental analysis module provides a way to measure Johnson Johnson's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Johnson Johnson stock.
At this time, Johnson Johnson's Income Tax Expense is relatively stable compared to the past year. Net Income From Continuing Ops is expected to hike to about 14.8 B this year, although the value of Other Operating Expenses will most likely fall to nearly 36.9 B. Johnson | Select Account or Indicator |
Johnson Johnson Company Return On Asset Analysis
Johnson Johnson's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Johnson Johnson Return On Asset | 0.084 |
Most of Johnson Johnson's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Johnson Johnson is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Johnson Total Assets
Total Assets |
|
Based on the latest financial disclosure, Johnson Johnson has a Return On Asset of 0.084. This is 100.96% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The return on asset for all United States stocks is 160.0% lower than that of the firm.
Johnson Johnson Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Johnson Johnson's current stock value. Our valuation model uses many indicators to compare Johnson Johnson value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Johnson Johnson competition to find correlations between indicators driving Johnson Johnson's intrinsic value. More Info.Johnson Johnson is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.40 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Johnson Johnson is roughly 2.49 . At this time, Johnson Johnson's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Johnson Johnson by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Johnson Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Johnson Johnson's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Johnson Johnson could also be used in its relative valuation, which is a method of valuing Johnson Johnson by comparing valuation metrics of similar companies.Johnson Johnson is currently under evaluation in return on asset category among its peers.
Johnson Johnson ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Johnson Johnson's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Johnson Johnson's managers, analysts, and investors.Environmental | Governance | Social |
Johnson Fundamentals
| Return On Equity | 0.21 | ||||
| Return On Asset | 0.084 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 390.51 B | ||||
| Shares Outstanding | 2.41 B | ||||
| Shares Owned By Insiders | 0.09 % | ||||
| Shares Owned By Institutions | 73.11 % | ||||
| Number Of Shares Shorted | 17.48 M | ||||
| Price To Earning | 24.69 X | ||||
| Price To Book | 5.35 X | ||||
| Price To Sales | 4.24 X | ||||
| Revenue | 85.16 B | ||||
| Gross Profit | 63.95 B | ||||
| EBITDA | 29.34 B | ||||
| Net Income | 13.33 B | ||||
| Cash And Equivalents | 5.37 B | ||||
| Cash Per Share | 13.03 X | ||||
| Total Debt | 29.33 B | ||||
| Debt To Equity | 0.43 % | ||||
| Current Ratio | 1.43 X | ||||
| Book Value Per Share | 29.14 X | ||||
| Cash Flow From Operations | 22.79 B | ||||
| Short Ratio | 2.54 X | ||||
| Earnings Per Share | 6.06 X | ||||
| Price To Earnings To Growth | 0.93 X | ||||
| Target Price | 174.89 | ||||
| Number Of Employees | 131.9 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 372.03 B | ||||
| Total Asset | 167.56 B | ||||
| Retained Earnings | 153.84 B | ||||
| Working Capital | 7.21 B | ||||
| Current Asset | 60.21 B | ||||
| Current Liabilities | 27.75 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 2.59 % | ||||
| Net Asset | 167.56 B | ||||
| Last Dividend Paid | 4.86 |
About Johnson Johnson Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Johnson Johnson's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Johnson Johnson using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Johnson Johnson based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 3.4 B | 4.5 B | |
| Total Revenue | 85.2 B | 49.3 B | |
| Cost Of Revenue | 26.7 B | 15 B | |
| Stock Based Compensation To Revenue | 0.01 | 0.01 | |
| Sales General And Administrative To Revenue | 0.24 | 0.28 | |
| Research And Ddevelopement To Revenue | 0.18 | 0.10 | |
| Capex To Revenue | 0.05 | 0.06 | |
| Revenue Per Share | 33.61 | 35.29 | |
| Ebit Per Revenue | 0.27 | 0.18 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Johnson Johnson Piotroski F Score and Johnson Johnson Altman Z Score analysis. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.89) | Dividend Share 4.86 | Earnings Share 6.06 | Revenue Per Share 36.428 | Quarterly Revenue Growth 0.052 |
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.